Craig C. Hopkinson - Feb 26, 2025 Form 4 Insider Report for Alkermes plc. (ALKS)

Role
EVP R&D, Chief Medical Officer
Signature
/s/ Shantale Greenson, attorney-in-fact for Craig C. Hopkinson
Stock symbol
ALKS
Transactions as of
Feb 26, 2025
Transactions value $
-$106,090
Form type
4
Date filed
2/28/2025, 05:16 PM
Previous filing
Feb 25, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKS Ordinary Shares Options Exercise +6.87K +9.29% 80.8K Feb 26, 2025 Direct F1
transaction ALKS Ordinary Shares Tax liability -$106K -3.05K -3.77% $34.80 77.7K Feb 26, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKS Restricted Stock Unit Award Options Exercise -6.87K -25% 20.6K Feb 26, 2025 Ordinary Shares 6.87K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share.
F2 Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025.